The Effect of Salient Reputational Threats on the Pace of FDA Enforcement

Governance

Volumn 26, Issue 1, 2013, Pages 31-61

  Maor, Moshe ^a   Sulitzeanu Kenan, Raanan ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868628208     PISSN: 09521895     EISSN: 14680491     Source Type: Journal    
DOI: 10.1111/j.1468-0491.2012.01601.x     Document Type: Article

References (66)

1. Arrow, Kenneth J. 1974. The Limits of Organization. New York: W.W. Norton.
2. Beck, U. 1992. Risk Society: Towards a New Modernity. London: Sage.
3. Bendor, Jonathan, and Terry M. Moe. 1985. "An Adaptive Model of Bureaucratic Politics. American Political Science Review 79 (September): 755-774.
4. Bohner, Gerd, and Nina Dickel. 2011. "Attitudes and Attitude Change. Annual Review of Psychology 62: 391-417.
5. Bramstedt, Katrina A. 2004. "A Study of Warning Letters Issued to Clinical Investigators by the United States Food and Drug Administration. Clinical & Investigative Medicine 27 (3): 129-134.
6. Brehm, John, and Scott Gates. 1997. Working, Shirking and Sabotage: Bureaucratic Response to a Democratic Public. Ann Arbor: University of Michigan Press.
7. Carpenter, Daniel P. 2001. The Forging of Bureaucratic Autonomy: Reputations, Networks, and Policy Innovation in Executive Agencies, 1862-1928. Princeton, NJ: Princeton University Press.
8. Carpenter, Daniel P. 2002. "Groups, the Media, Agency Waiting Costs, and FDA Drug Approval. American Journal of Political Science 46 (July): 490-505.
9. Carpenter, Daniel P. 2003. "Why Do Bureaucrats Delay? Lessons from a Stochastic Optimal Stopping Model of Agency Timing, with Applications to the FDA." In Politics, Policy, and Organizations Frontiers in the Scientific Study of Bureaucracy, ed. George A. Krause and Kenneth J. Meier. Ann Arbor: University of Michigan Press.
10. Carpenter, Daniel P. 2004. "Protection without Capture: Dynamic Product Approval by a Politically Responsive, Learning Regulator. American Political Science Review 98: 613-631.
11. Carpenter, Daniel P. 2010a. Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA. Princeton, NJ: Princeton University Press.
12. Carpenter, Daniel P. 2010b. "Institutional Strangulation: Bureaucratic Politics and Financial Reform in the Obama Administration," Perspectives on Politics 8: 825-846.
13. Carpenter, Daniel P., Jacqueline Chattopadhyay, Susan Moffitt, Justin Grimmer, Jake Bowers, Clayton Nall, and Evan James Zucker. 2009. "Deadline Effects in Regulatory Review: A Methodological and Empirical Analysis." Working Paper Series WP-45, RWJFS Scholars in Health Policy Research Program, The Robert Wood Johnson Foundation.
14. Carpenter, Daniel P., and Justin Grimmer. 2009. "The Downsize of Deadlines." Working Paper Series WP-41, RWJFS Scholars in Health Policy Research Program, The Robert Wood Johnson Foundation.
15. Carpenter, Daniel P., Evan James Zucker, and Jerry Avorn. 2008. "Drug-Review Deadlines and Safety Problems. New England Journal of Medicine 358 (13): 1354-1361.
16. Cooper, Richard M., and John R. Fleder. 2005. "Responding to a Form 483 or Warning Letter: A Practical Guide. Food and Drug Law Journal 60 (4): 479-493.
17. Elster, Jon. 1998. "Emotions and Economic Theory. Journal of Economic Literature 36: 47-74.
18. Feldman, Marth S., and Brian T. Pentland. 2003. "Reconceptualizing Organizational Routines as a Source of Flexibility and Change. Administrative Science Quarterly 48: 94-118.
19. Forgas, Joseph P. 1995. "Mood and Judgment: The Affect Infusion Model (AIM). Psychological Bulletin 117: 39-66.
20. Gersen, Jacob, and Anne Joseph O'Connell. 2008. "Deadlines in Administrative Law. University of Pennsylvania Law Review 156 (4): 924-990.
21. Gilad, Sharon, Moshe Maor, and Pazit Ben-Nun Bloom. 2012. "Organizational Reputation, the Content of Public Allegations and Regulatory Communication." Paper presented at the International Political Science Association World Congress, Madrid, July.
22. Hammond, Thomas H. 1986. "Agenda Control, Organizational Structure, and Bureaucratic Politics. American Journal of Political Science 30: 379-420.
23. Hammond, Thomas H., and Jack H. Knott. 1996. "Who Controls the Bureaucracy? Presidential Power, Congressional Dominance, Legal Constraints, and Bureaucratic Autonomy in a Model of Multi-Institutional Policymaking. Journal of Law, Economics and Organization 12 (April): 119-166.
24. Hammond, Thomas H., and Paul A. Thomas. 1989. "The Impossibility of a Neutral Hierarchy. Journal of Law, Economics, and Organization 5: 155-184.
25. Heimann, C. F. Larry. 1997. Acceptable Risks: Politics, Policy and Risky Technologies. Ann Arbor: University of Michigan Press.
26. Hood, Christopher. 2002. "The Risk Game and the Blame Game. Government and Opposition 37 (1): 15-37.
27. Hood, Christopher. 2011. The Blame Game: Spin, Bureaucracy, and Self-Preservation in Government. Princeton, NJ: Princeton University Press.
28. Hood, Christopher, Will Jennings, Ruth Dixon, Brian Hogwood, and Craig Beeston. 2009. "Testing Times: Exploring Staged Responses and the Impact of Blame Management Strategies in Two Examination Fiasco Cases. European Journal of Political Research 48: 695-722.
29. Huber, John D., and Charles R. Shipan. 2002. Deliberate Discretion? The Institutional Foundations of Bureaucratic Autonomy. New York: Cambridge University Press.
30. Joskow, Paul. 1974. "Inflation and Environmental Concern: Structural Change in the Process of Public Utility Price Regulation. Journal of Law and Economics 17: 291-327.
31. Kasperson, Roger E. 1992. "The Social Amplification of Risk: Progress in Developing an Integrative Framework." In Social Theories of Risk, ed. Sheldon Krimsky and Dominic Golding. Westport, CT: Praeger.
32. Kleinbaum, David G., and Mitchel Klein. 2005. Survival Analysis: A Self-Learning Text. 2nd ed. New York: Springer.
33. Kosnik, Lea-Rachel D. 2005. "Sources of Bureaucratic Delay: A Case Study of FERC Dam Relicensing. Journal of Law Economics and Organization 22 (1): 258-288.
34. Krause, George A., and James W. Douglas. 2005. "Institutional Design versus Reputational Effects on Bureaucratic Performance: Evidence from U.S. Government Macroeconomic and Fiscal Projections. Journal of Public Administration Research and Theory 15: 281-306.
35. Lavertu, Stéphane, and David Weimer. 2009. "Information Costs, Policy Uncertainty, and Political Control: Federal Advisory Committees at the FDA. Journal of Public Administration Research and Theory 21 (2): 211-237.
36. Maor, Moshe. 2007. "A Scientific Standard and an Agency's Legal Independence: Which of These Reputation-Protection Mechanisms Is Less Susceptible to Political Moves. Public Administration 85 (4): 961-978.
37. Maor, Moshe. 2010. "Organizational Reputation and Jurisdictional Claims: The Case of the U.S. Food and Drug Administration. Governance 23 (1): 133-159.
38. Maor, Moshe. 2011. "Organizational Reputations and the Observability of Public Warnings in 10 Pharmaceutical Markets. Governance 24 (3): 557-582.
39. Maor, Moshe, and Sharon Gilad. 2011. "Organizational Reputation, Regulatory Talk and Strategic Silence." Paper presented at the ECPR General Conference, Reykjavik, August 25-27.
40. Maor, Moshe, Sharon Gilad, and Pazit Ben-Nun Bloom. 2012. "Organizational Reputation, Regulatory Talk and Strategic Silence." Paper presented at the Transatlantic Conference on Trasparency Research, University of Utrecht, the Netherlands.
41. May, Peter J., Workman Samuel, and Bryan D. Jones. 2008. "Organizing Attention: Responses of the Bureaucracy to Agenda Disruption. Journal of Public Administration Research and Theory 18 (4): 517-541.
42. McCubbins, Mathew D., and Thomas Schwartz. 1984. "Congressional Oversight Overlooked: Policy Patrols versus Fire Alarms. American Journal of Political Science 28 (February): 165-179.
43. Moe, Terry M. 1982. "Regulatory Performance and Presidential Administration. American Journal of Political Science 26 (May): 197-224.
44. Moe, Terry M. 1985. "Control and Feedback in Economic Regulation: The Case of NLRB. American Political Science Review 79: 1094-1116.
45. Moe, Terry M. 2006. "Political Control and the Power of the Agent. Journal of Law, Economics, and Organization 22: 1-29.
46. Moffitt, Susan. 2002. "Inviting Outsiders In: Reputation and Agency Strategy for Advisory Committee Consultation." Paper presented at the annual meeting of the American Political Science Association, Boston.
47. Olson, Mary. 1997. "Firm Characteristics and the Speed of FDA Approval. Journal of Economics and Management Strategy 6: 377-401.
48. Pierson, Paul. 2004. Politics in Time: History, Institutions and Social Analysis. Princeton, NJ: Princeton University Press.
49. Pollitt, Christopher. 2008. Time, Policy and the Past: Governing with the Past. Oxford: Oxford University Press.
50. Quirk, Paul. 1980. "The Food and Drug Administration." In The Politics of Regulation, ed. James Q. Wilson. New York: Basic Books.
51. Ruef, Martin, and Richard W. Scott. 1998. "A Multidimensional Model of Organizational Legitimacy: Hospital Survival in Changing Institutional Environments. Administrative Science Quarterly 43 (4): 877-904.
52. Salas, Maribel, Michelle Martin, Maria Pisu, Erin McCall, Alvaro Zuluaga, and Stephen P. Glasser. 2008. "Analysis of US Food and Drug Administration Warning Letters: False Promotional Claims Relating to Prescription and Over-the-Counter Medications. Pharmaceutical Medicine 22 (2): 119-125.
53. Sheafer, Tamir. 2007. "Hoe to Evaluate It: The Role of Story-Evaluative Tone in Agenda Setting and Priming. Journal of Communication 57: 21-39.
54. Soroka, Stuart N. 2006. "Good News and Bad News: Asymmetric Responses to Economic Information. Journal of Politics 68 (2): 372-385.
55. Stewart, Kate A., and Peter J. Neumann. 2002. "FDA Actions against Misleading or Unsubstantiated Economic and Quality-of-Life Promotional Claims: An Analysis of Warning Letters and Notices of Violation. Value in Health 5 (5): 389-396.
56. Sulitzeanu-Kenan, Raanan. 2010. "Reflection in the Shadow of Blame: When Do Politicians Appoint Commissions of Inquiry? British Journal of Political Science 40 (3): 613-634.
57. Sunstein, Cass R. 1999. "Selective Fatalism. Journal of Legal Studies 27: 799-823.
58. Tversky, Amos, and Daniel Kahneman. 1981. "The Framing of Decisions and the Psychology of Choice. Science 211: 453-458.
59. Walgrave, Stefaan, Stuart Soroka, and Michiel Nuytemans. 2008. "The Mass Media's Political Agenda-Setting Power: A Longitudinal Analysis of Media, Parliament, and Government in Belgium (1993 to 2000). Comparative Political Studies 41 (6): 814-836.
60. Weaver, R. Kent. 1986. "The Politics of Blame Avoidance. Journal of Public Policy 6 (4): 371-398.
61. Weingast, Barry R., and Mark J. Moran. 1983. "Bureaucratic Discretion or Congressional Control? Regulatory Policymaking by the Federal Trade Commission. Journal of Political Economy 91 (October): 756-800.
62. Whitford, Andrew. 2005. "The Pursuit of Political Control by Multiple Principals. Journal of Politics 67 (1): 28-49.
63. Wilshir, Colin R. 2002. "A Qualitative Examination of FDA Warning Letters-What Can We Learn from GCP Inspections?" Quality Assurance Journal 6: 143-157.
64. Wood, B. Dan. 1988. "The Principals, Bureaucrats, and Responsiveness in Clean Air Enforcement. American Political Science Review 82 (March): 213-234.
65. Wood, B. Dan, and Richard W. Waterman. 1991. "The Dynamics of Political Control of the Bureaucracy. American Political Science Review 85 (September): 801-828.
66. Yackee, Jason, and Susan W. Yackee. 2010. "Administrative Procedures and Bureaucratic Performance: Is Federal Rulemaking 'Ossified'. Journal of Public Administration Research and Theory 20 (2): 261-282.